(l to r) Dr. Darci Sidwell, Dr. Stuart Berr
, Dr. Brent French and Dr. James Stone in front of the cyclotron, a circular particle accelerator that weighs over 50,000 pounds. (Click on photo for high resolution)
Stuart Berr, PhD, professor of research in radiology and biomedical engineering, and director of the UVA Molecular Imaging Core Lab who spearheaded the cyclotron project, explains the technology's broad disease applications.
"One immediate use of this technology will be to assess the effectiveness of a particular cancer therapy," he
"We'll be able to do ammonia imaging to image cardiac blood flow to see if people have blockages of their coronary arteries," Berr
"So it will be very useful be able to make these short-lived biomarkers and get them to the medical center quickly," Berr
The technology, located at UVA's
Sheridan G. Snyder Translational Research Building at Fontaine Research Park, was purchased through a 2008 grant from the National Institutes of Health
and is operated in partnership with PETNET
, a subsidiary of Siemens Medical Solutions.
Dr. Berr served as principal investigator of the grant.
Stuart S. Berr, PhD, professor of research, Radiology and Biomedical Engineering, director of the UVA Molecular Imaging Core Lab, and principal investigator of the NIH grant used to purchase the cyclotron;